FDA Inspection 1219959 — PenCef Pharma GmbH

PenCef Pharma GmbH — FEI 3008654273

The FDA completed an inspection of PenCef Pharma GmbH on September 27, 2023 in Berlin. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 27, 2023
Fiscal Year
2023
Product Type
Veterinary
Project Area
Pre-Approval Eval. of Animal Drugs and Food Additives
Location
Berlin (Germany)

Citations

IDCFRDescription
126321 CFR 211.68(b)Computer control of master formula records
136121 CFR 211.100(a)Absence of Written Procedures
138821 CFR 211.101(d)Component addition checked by 2nd person
200921 CFR 211.188Prepared for each batch, include complete information
440221 CFR 211.192Written record of investigation incomplete